ASMANEX TWISTHALER

Asmanex Twisthaler Adverse Events Reported to the FDA Over Time

How are Asmanex Twisthaler adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Asmanex Twisthaler, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Asmanex Twisthaler is flagged as the suspect drug causing the adverse event.

Most Common Asmanex Twisthaler Adverse Events Reported to the FDA

What are the most common Asmanex Twisthaler adverse events reported to the FDA?

Product Quality Issue	65 (5.01%)
Drug Dose Omission	64 (4.93%)
Dyspnoea	37 (2.85%)
No Adverse Event	34 (2.62%)
Asthma	30 (2.31%)
Condition Aggravated	20 (1.54%)
Drug Ineffective	20 (1.54%)
Cough	19 (1.46%)
Device Malfunction	18 (1.39%)
Wheezing	17 (1.31%)
Chest Pain	13 (1%)
	Show More
Off Label Use	12 (.93%)
Swollen Tongue	12 (.93%)
Death	11 (.85%)
Loss Of Consciousness	11 (.85%)
Oropharyngeal Pain	11 (.85%)
Chest Discomfort	10 (.77%)
Device Failure	10 (.77%)
Nausea	10 (.77%)
Palpitations	10 (.77%)
Rash	10 (.77%)
Abdominal Pain	9 (.69%)
Headache	9 (.69%)
Tremor	9 (.69%)
Aphonia	8 (.62%)
Asthenia	8 (.62%)
Candidiasis	8 (.62%)
Drug Hypersensitivity	8 (.62%)
Epistaxis	8 (.62%)
Fatigue	8 (.62%)
Incorrect Dose Administered	8 (.62%)
Insomnia	8 (.62%)
Pain	8 (.62%)
Convulsion	7 (.54%)
Depression	7 (.54%)
Dizziness	7 (.54%)
Pain In Extremity	7 (.54%)
Pneumonia	7 (.54%)
Throat Tightness	7 (.54%)
Urticaria	7 (.54%)
Weight Decreased	7 (.54%)
Anaphylactic Reaction	6 (.46%)
Blindness Unilateral	6 (.46%)
Dysphonia	6 (.46%)
Malaise	6 (.46%)
Medical Device Complication	6 (.46%)
Myocardial Infarction	6 (.46%)
Throat Irritation	6 (.46%)
Blood Pressure Increased	5 (.39%)
Burning Sensation	5 (.39%)
Fall	5 (.39%)
Haemoptysis	5 (.39%)
Hypersensitivity	5 (.39%)
Lip Swelling	5 (.39%)
Nervousness	5 (.39%)
Oedema Peripheral	5 (.39%)
Overdose	5 (.39%)
Paraesthesia	5 (.39%)
Staphylococcal Infection	5 (.39%)
Subcutaneous Abscess	5 (.39%)
Syncope	5 (.39%)
Vision Blurred	5 (.39%)
Vomiting	5 (.39%)
Weight Increased	5 (.39%)
Accidental Exposure	4 (.31%)
Aggression	4 (.31%)
Anxiety	4 (.31%)
Arthralgia	4 (.31%)
Bronchopulmonary Aspergillosis	4 (.31%)
Cardiac Disorder	4 (.31%)
Cardiac Failure Congestive	4 (.31%)
Diarrhoea	4 (.31%)
Dysgeusia	4 (.31%)
Feeling Abnormal	4 (.31%)
Gait Disturbance	4 (.31%)
Gastrooesophageal Reflux Disease	4 (.31%)
Glossodynia	4 (.31%)
Hot Flush	4 (.31%)
Hypertension	4 (.31%)
Hypoaesthesia	4 (.31%)
Lung Infection	4 (.31%)
Mouth Ulceration	4 (.31%)
Myalgia	4 (.31%)
Myopathy	4 (.31%)
Oral Pain	4 (.31%)
Paranoia	4 (.31%)
Product Contamination	4 (.31%)
Pruritus	4 (.31%)
Rash Erythematous	4 (.31%)
Sleep Disorder	4 (.31%)
Suicidal Ideation	4 (.31%)
Swelling Face	4 (.31%)
Transient Ischaemic Attack	4 (.31%)
Unevaluable Event	4 (.31%)
Wrong Technique In Drug Usage Proce...	4 (.31%)
Anorexia	3 (.23%)
Anosmia	3 (.23%)
Bronchospasm	3 (.23%)
Cataract	3 (.23%)
Cerebrovascular Accident	3 (.23%)
Chronic Obstructive Pulmonary Disea...	3 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Asmanex Twisthaler, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Asmanex Twisthaler is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Asmanex Twisthaler

What are the most common Asmanex Twisthaler adverse events reported to the FDA?

Respiratory	120 (9.25%)
Medication Errors	100 (7.71%)
Product Quality Issues	71 (5.47%)
Neurological	59 (4.55%)
Bronchial Disorders	54 (4.16%)
Epidermal And Dermal Conditions	40 (3.08%)
Procedural And Device Related Injur...	40 (3.08%)
Therapeutic And Nontherapeutic Effe...	38 (2.93%)
Gastrointestinal Signs	35 (2.7%)
Infections - Pathogen Unspecified	30 (2.31%)
Allergic Conditions	24 (1.85%)
	Show More
Oral Soft Tissue Conditions	22 (1.7%)
Fungal Infectious	21 (1.62%)
Tongue Conditions	20 (1.54%)
Upper Respiratory Tract Disorders	19 (1.46%)
Muscle	17 (1.31%)
Cardiac Disorder Signs	16 (1.23%)
Vision	16 (1.23%)
Injuries	15 (1.16%)
Musculoskeletal And Connective Tiss...	14 (1.08%)
Physical Examination Topics	14 (1.08%)
Sleep Disorders	13 (1%)
Anxiety Disorders	12 (.93%)
Fatal Outcomes	12 (.93%)
Gastrointestinal Motility And Defec...	12 (.93%)
Therapeutic Procedures And Supporti...	12 (.93%)
Cardiac And Vascular Investigations	11 (.85%)
Bacterial Infectious	10 (.77%)
Cardiac Arrhythmias	10 (.77%)
Angiedema And Urticaria	9 (.69%)
Headaches	9 (.69%)
Movement Disorders	9 (.69%)
Bone And Joint Injuries	8 (.62%)
Coronary Artery	8 (.62%)
Joint	8 (.62%)
Personality Disorders	8 (.62%)
Skin Appendage Conditions	8 (.62%)
Central Nervous System Vascular	7 (.54%)
Depressed Mood Disorders	7 (.54%)
Lifestyle Issues	7 (.54%)
Metabolic, Nutritional And Blood Ga...	7 (.54%)
Seizures	7 (.54%)
Vascular	7 (.54%)
Disturbances In Thinking	6 (.46%)
Eye	5 (.39%)
Heart Failures	5 (.39%)
Skin And Subcutaneous Tissue	5 (.39%)
Appetite And General Nutritional	4 (.31%)
Bone Disorders	4 (.31%)
Lower Respiratory Tract Disorders	4 (.31%)
Mental Impairment	4 (.31%)
Metabolism	4 (.31%)
Neurological, Special Senses And Ps...	4 (.31%)
Respiratory And Pulmonary Investiga...	4 (.31%)
Suicidal And Self-injurious Behavio...	4 (.31%)
Tendon, Ligament And Cartilage	4 (.31%)
Vascular Hypertensive	4 (.31%)
Anterior Eye Structural Change, Dep...	3 (.23%)
Aural	3 (.23%)
Cranial Nerve Disorders	3 (.23%)
Decreased And Nonspecific Blood Pre...	3 (.23%)
Gastrointestinal Conditions	3 (.23%)
Glaucoma And Ocular Hypertension	3 (.23%)
Malabsorption Conditions	3 (.23%)
Mood Disorders	3 (.23%)
Ocular Structural Change, Deposit A...	3 (.23%)
Renal Disorders	3 (.23%)
Salivary Gland Conditions	3 (.23%)
Viral Infectious	3 (.23%)
Water, Electrolyte And Mineral	3 (.23%)
Adrenal Gland	2 (.15%)
Body Temperature Conditions	2 (.15%)
Cervix Disorders	2 (.15%)
Cognitive And Attention Disorders	2 (.15%)
Deliria	2 (.15%)
Dental And Gingival Conditions	2 (.15%)
Exocrine Pancreas Conditions	2 (.15%)
Gastrointestinal Ulceration And Per...	2 (.15%)
Glucose Metabolism Disorders	2 (.15%)
Inner Ear And Viiith Cranial Nerve	2 (.15%)
Menstrual Cycle And Uterine Bleedin...	2 (.15%)
Myocardial	2 (.15%)
Ocular Infections, Irritations And ...	2 (.15%)
Ovarian And Fallopian Tube	2 (.15%)
Renal And Urinary Tract Investigati...	2 (.15%)
Respiratory And Mediastinal Neoplas...	2 (.15%)
Tissue	2 (.15%)
Urinary Tract Signs	2 (.15%)
Anal And Rectal Conditions	1 (.08%)
Breast	1 (.08%)
Cardiac Valve	1 (.08%)
Changes In Physical Activity	1 (.08%)
Chemical Injury And Poisoning	1 (.08%)
Communication Disorders	1 (.08%)
Economic And Housing Issues	1 (.08%)
Electrolyte And Fluid Balance Condi...	1 (.08%)
Environmental Issues	1 (.08%)
External Ear Disorders	1 (.08%)
Eye Therapeutic Procedures	1 (.08%)
Gastrointestinal Hemorrhages	1 (.08%)
Gastrointestinal Tract Disorders Co...	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Asmanex Twisthaler, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Asmanex Twisthaler is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.